Increased cervical cancer risk associated with screening at longer intervals.
about
The clinical implementation of primary HPV screening.Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years.A Suggested Approach to Simplify and Improve Cervical Screening in the United States.Identifying a "range of reasonable options" for cervical cancer screening.The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.How Colposcopy Misses Invasive Cervical Cancer: A Case Report from the IMPROVE-COLPO Study.A cohort study of cervical screening using partial HPV typing and cytology triage.Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.Risk stratification in cervical cancer screening by complete screening history: Applying bioinformatics to a general screening population.The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.Trends in Pap test practices and results: An 11-year review of the annual ACHA Pap Test and STI Survey.Why does cervical cancer occur in a state-of-the-art screening program?Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.Digital Colposcopy With Dynamic Spectral Imaging for Detection of Cervical Intraepithelial Neoplasia 2+ in Low-Grade Referrals: The IMPROVE-COLPO Study.HPV primary screening: unanswered questions.Gynaecological cancer: New standard of care—HPV testing for cervical cancer screening.
P2860
Q30238954-8B9D60D9-90B8-4DE8-8372-956980313FDDQ30299986-93538D24-2DEB-405B-A41E-A6F9AD21FE1AQ36407125-AD705AD2-DA17-4FC4-BC91-23AE3E52E4A1Q36483052-1F2BDA03-803A-469B-9423-502814974E9CQ36987575-17F4B675-0C49-459F-840E-36D1C207467FQ37382672-DB6C371A-C195-4BAD-A4A9-F78BCB327754Q38378838-D2035E5A-3D8E-4341-8E09-F71F78C36263Q38789321-33B76631-50CF-4035-8A9A-BE067AFA0803Q38850741-A99EA640-6FE0-4948-944D-004C30A46BC7Q39362235-C36AE3FF-DF9C-4ECE-AA95-BCDD193EEF13Q39378453-E6360320-1C9B-463A-8F73-3E4E8C8D0626Q40162758-4D6108DF-5D25-410E-B2B6-E5F5D3CBFB06Q41189811-1975CDA6-AB10-4AD0-83D7-CB16EABC6EC5Q42369427-EFC0E53C-502E-41CB-ACF1-E7CAD215B99AQ46702041-EED11AD9-6FF6-4B5C-895B-F2CF1FF404D9Q48534829-8E72B1B6-BB21-4C2E-8B4D-C6E16C440578Q50935034-98597612-96B6-43C8-B6D9-7FFB580A4C20Q51056471-915314DF-D7AF-47CD-A101-D741AF7D3AFF
P2860
Increased cervical cancer risk associated with screening at longer intervals.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Increased cervical cancer risk associated with screening at longer intervals.
@en
Increased cervical cancer risk associated with screening at longer intervals.
@nl
type
label
Increased cervical cancer risk associated with screening at longer intervals.
@en
Increased cervical cancer risk associated with screening at longer intervals.
@nl
prefLabel
Increased cervical cancer risk associated with screening at longer intervals.
@en
Increased cervical cancer risk associated with screening at longer intervals.
@nl
P2093
P1476
Increased cervical cancer risk associated with screening at longer intervals.
@en
P2093
Helen E Dinkelspiel
J Thomas Cox
Mark DeFrancesco
Thomas C Wright
Walter Kinney
Warner Huh
P304
P356
10.1097/AOG.0000000000000632
P407
P577
2015-02-01T00:00:00Z